| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |